Text Only Version A A A

bpas comment on the Scottish government's decision to permit home use of prescribed misoprostol

Ann Furedi, CEO of bpas, said: 

"We thoroughly welcome the Scottish government’s decision. This will spare women not only the difficulties associated with having to make more than one clinic visit – childcare, transport, time off work – but it will also spare women from the risk of symptoms on their way home, having taken the medication in a clinic.

"It is simply perverse that a woman arriving at a bpas clinic in England and Wales with an incomplete miscarriage can be given the medication to take in the comfort and privacy of her own home, while a woman seeking an abortion must take that same medication on site. We hope that the government will follow Scotland’s lead and roll out this important policy change across the rest of Great Britain."


Notes to Editors:

About bpas

bpas is a charity which sees more than 70,000 women a year and provides reproductive healthcare services including pregnancy counselling, abortion care, miscarriage management and contraception, at clinics across the UK. It supports and advocates for reproductive choice. More information can be found at bpas.org.